In conclusion, this is the first comprehensive study of a large NSCLC cohort, not only to explore the expression of PD-L1 on tumor and infiltrating immune cells, but also to analyze the relationship between PD-L1 expression and other important NSCLC genetic drivers. Here, CD274 is linked to neoplasm.